Skip to content
Screener

Revvity RVTY Q2 2025 earnings

Reported July 28, 2025 · Before market open

Revenue$720.3MBeat by $20.4M
EPS$1.18Beat by $0.04
Revenue estimate$699.9M
EPS estimate$1.14

Next report

Oct 26, 2026 (in 2 months)
Revenue estimate$694.1M
EPS estimate$1.28

Financials

Q2 2025

Income statement

See full
Revenue$720.3M+4.1%
Gross profit$392.6M+1.8%
Operating income$90.8M+5.9%
Net income$53.9M-2.6%
EPS (diluted)$0.46+2.2%

Balance sheet

See full
Cash & equivalents$993.0M-20.5%
Total debt$3.4B-28.2%
Total equity$7.6B-4.0%
Total assets$12.4B-7.9%

Cash flow

See full
Operating cash flow$134.3M-15.3%
CapEx$18.9M-14.4%
Free cash flow$115.5M-15.5%

Valuation & ratios

Valuation

as of 06/29/25
See full
Market cap$11.36B-12.2%
Enterprise value$13.77B-16.2%
P/E39.8×-36.6×
P/S4.1×-0.7×

Profitability

See full
Operating margin13.6%+3.4pp
Net margin10.2%+3.9pp
FCF margin18%+3.8pp

Returns & leverage

See full
Return on equity3.7%+1.5pp
Debt / equity0.4×-0.2×
Current ratio3.3×+1.1×

Segments

By geography

See full
UNITED STATES$281.6M—
CHINA$106.3M—
GERMANY$44.4M—
UNITED KINGDOM$31.7M—

By segment

See full
Life Sciences$365.9M—
Diagnostics$354.4M—

By product

See full
Service$109.6M+6.8%

FAQ

When did Revvity report Q2 2025 earnings?
Revvity (RVTY) reported Q2 2025 earnings on July 28, 2025 before market open.
What were Revvity's Q2 2025 revenue and EPS?
Revvity reported revenue of $720.3M and eps of $1.18 for Q2 2025.
Did Revvity beat estimates in Q2 2025?
Revenue beat the consensus estimate of $699.9M by $20.4M. EPS beat the consensus estimate of $1.14 by $0.04.
How did Revvity's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 4.1% from $691.7M a year earlier and eps declined 3.3% from $1.22.
Where can I find Revvity's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000031791-25-000022) and the 10-Q periodic report (0000031791-25-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.